COMPARISON STUDY BETWEEN PROMONITOR QUICK IFX AND QUANTUM BLUE® INFLIXIMAB FOR THE QUANTIFICATION OF INFLIXIMAB LEVELS

Ainhoa Ruiz del Agua  ¹     Noelia Rapún  ¹     María Begoña Ruiz-Argüello  ¹     Daniel Nagore  ¹     Paul L.A.M. Corstjens  ²     Claudia J. de Dood  ²     Amagoia Ametzazurra  ^2    
1 Progenika Biopharma SA, a subsidiary of Grifols SA, Derio, Spain
² Leiden University Medical Center, Leiden, Netherlands

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)